De Wolf Julien, Glorion Matthieu, Jouneau Luc, Estephan Jérôme, Leplat Jean-Jacques, Blanc Fany, Richard Christophe, Urien Céline, Roux Antoine, Le Guen Morgan, Journois Didier, Schwartz-Cornil Isabelle, Sage Edouard
Department of Thoracic Surgery and Lung Transplantation, Foch Hospital, Suresnes, France.
INRAE, UVSQ, VIM, Université Paris-Saclay, Jouy-en-Josas, France.
Transplantation. 2022 May 1;106(5):979-987. doi: 10.1097/TP.0000000000003931. Epub 2021 Aug 30.
Normothermic ex vivo lung perfusion (EVLP) increases the pool of donor lungs by requalifying marginal lungs refused for transplantation through the recovery of macroscopic and functional properties. However, the cell response and metabolism occurring during EVLP generate a nonphysiological accumulation of electrolytes, metabolites, cytokines, and other cellular byproducts which may have deleterious effects both at the organ and cell levels, with impact on transplantation outcomes.
We analyzed the physiological, metabolic, and genome-wide response of lungs undergoing a 6-h EVLP procedure in a pig model in 4 experimental conditions: without perfusate modification, with partial replacement of fluid, and with adult or pediatric dialysis filters.
Adult and pediatric dialysis stabilized the electrolytic and metabolic profiles while maintaining acid-base and gas exchanges. Pediatric dialysis increased the level of IL-10 and IL-6 in the perfusate. Despite leading to modification of the perfusate composition, the 4 EVLP conditions did not affect the gene expression profiles, which were associated in all cases with increased cell survival, cell proliferation, inflammatory response and cell movement, and with inhibition of bleeding.
Management of EVLP perfusate by periodic replacement and continuous dialysis has no significant effect on the lung function nor on the gene expression profiles ex vivo. These results suggest that the accumulation of dialyzable cell products does not significantly alter the lung cell response during EVLP, a finding that may have impact on EVLP management in the clinic.
常温离体肺灌注(EVLP)通过恢复宏观和功能特性,使原本因边缘状态而被拒绝用于移植的供肺重新符合标准,从而增加了供肺库。然而,EVLP过程中发生的细胞反应和代谢会导致电解质、代谢物、细胞因子及其他细胞副产物的非生理性积累,这可能在器官和细胞水平产生有害影响,进而影响移植结果。
我们在猪模型中分析了在4种实验条件下接受6小时EVLP程序的肺的生理、代谢和全基因组反应:不进行灌注液改良、部分更换液体以及使用成人或儿童透析滤器。
成人和儿童透析稳定了电解质和代谢谱,同时维持了酸碱平衡和气体交换。儿童透析增加了灌注液中IL-10和IL-6的水平。尽管导致了灌注液成分的改变,但这4种EVLP条件均未影响基因表达谱,在所有情况下,基因表达谱都与细胞存活增加、细胞增殖、炎症反应和细胞移动增加以及出血抑制相关。
通过定期更换和持续透析来管理EVLP灌注液,对离体肺功能和基因表达谱均无显著影响。这些结果表明,可透析细胞产物的积累在EVLP期间不会显著改变肺细胞反应,这一发现可能会对临床中的EVLP管理产生影响。